Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of Myocardial Injury in Patients With COVID-19.
Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, Danilov T, Kukar N, Shaban N, Kini A, Camaj A, Bienstock SW, Rashed ER, Rahman K, Oates CP, Buckley S, Elbaum LS, Arkonac D, Fiter R, Singh R, Li E, Razuk V, Robinson SE, Miller M, Bier B, Donghi V, Pisaniello M, Mantovani R, Pinto G, Rota I, Baggio S, Chiarito M, Fazzari F, Cusmano I, Curzi M, Ro R, Malick W, Kamran M, Kohli-Seth R, Bassily-Marcus AM, Neibart E, Serrao G, Perk G, Mancini D, Reddy VY, Pinney SP, Dangas G, Blasi F, Sharma SK, Mehran R, Condorelli G, Stone GW, Fuster V, Lerakis S, Goldman ME. Giustino G, et al. Among authors: razuk v. J Am Coll Cardiol. 2020 Nov 3;76(18):2043-2055. doi: 10.1016/j.jacc.2020.08.069. J Am Coll Cardiol. 2020. PMID: 33121710 Free PMC article.
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
Nicolas J, Beerkens F, Cao D, Sartori S, Pivato CA, Qiu H, Giustino G, Chiarito M, Claessen BE, Zhang Z, Nardin M, Razuk V, Jones D, Camaj A, Power D, Banashefski B, Sweeny J, Baber U, Dangas G, Sharma SK, Kini A, Mehran R. Nicolas J, et al. Among authors: razuk v. J Thromb Thrombolysis. 2022 Jan;53(1):20-29. doi: 10.1007/s11239-021-02534-z. Epub 2021 Aug 4. J Thromb Thrombolysis. 2022. PMID: 34347202
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention.
Pivato CA, Jones D, Cao D, Sartori S, Chiarito M, Nicolas J, Zhang Z, Beerkens F, Nardin M, Qiu H, Razuk V, Feldman D, Kumaraguru V, Stefanini GG, Sweeny J, Baber U, Dangas G, Sharma SK, Kini A, Mehran R. Pivato CA, et al. Among authors: razuk v. Can J Cardiol. 2022 Jun;38(6):792-800. doi: 10.1016/j.cjca.2022.02.002. Epub 2022 Feb 10. Can J Cardiol. 2022. PMID: 35151783
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
Razuk V, Chiarito M, Cao D, Nicolas J, Pivato CA, Camaj A, Power D, Beerkens F, Jones D, Alter A, Mathew A, Spirito A, Contreras JP, Dangas GD, Mehran R. Razuk V, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3;8(6):557-567. doi: 10.1093/ehjcvp/pvac001. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35021205
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
Beerkens FJ, Singh R, Cao D, Claessen BE, Nicolas J, Sartori S, Snyder C, Camaj A, Giustino G, Power D, Razuk V, Jones D, Tavenier AH, Pivato CA, Nardin M, Chiarito M, Krishnan P, Barman N, Baber U, Sweeny J, Dangas G, Sharma SK, Mehran R, Kini A. Beerkens FJ, et al. Among authors: razuk v. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E785-E795. doi: 10.1002/ccd.29935. Epub 2021 Sep 3. Catheter Cardiovasc Interv. 2021. PMID: 34478235
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Razuk V, Camaj A, Cao D, Nicolas J, Hengstenberg C, Sartori S, Zhang Z, Power D, Beerkens F, Chiarito M, Meneveau N, Tron C, Dumonteil N, Widder JD, Ferrari M, Violini R, Stella PR, Jeger R, Anthopoulos P, Mehran R, Dangas GD. Razuk V, et al. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E870-E880. doi: 10.1002/ccd.29753. Epub 2021 May 12. Catheter Cardiovasc Interv. 2021. PMID: 33909348 Clinical Trial.
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Feldman D, Cao D, Sartori S, Zhang Z, Hengstenberg C, Tron C, Anthopoulos P, Widder JD, Meneveau N, Stella PR, Ferrari M, Jeger R, Violini R, Dumonteil N, Chen S, Yan R, Nicolas J, Razuk V, Spirito A, Vogel B, Mehran R, Dangas G. Feldman D, et al. Among authors: razuk v. Catheter Cardiovasc Interv. 2023 May;101(6):1134-1143. doi: 10.1002/ccd.30647. Epub 2023 Apr 10. Catheter Cardiovasc Interv. 2023. PMID: 37036268 Clinical Trial.